| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d744495a72db4f1d2465358610b0c691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e17596cb58229204e29f19810017a007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f02a48a71f4d85d42cfae420d3bf7e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d4acf8e67a810f332df5921d82fc7f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6694a6dd195939712600dabccdfd9fc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
| filingDate |
2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a397d38c3c06779c1bc963e8d2f424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6057dee0fdbbfdfc8e6346b60336b481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d484948815efa4eb0efa9a3f6f9f3db3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f049e45a5562f58abc699a2ec4dcc563 |
| publicationDate |
2012-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012035260-A1 |
| titleOfInvention |
Tellurium-containing compounds for affecting female's reproductive system following chemotherapy and/or radiotherapy |
| abstract |
Use of tellurium-containing compounds in a method of conception and/or for maintaining and/or augmenting fertility in female following chemotherapy and/or radiotherapy is disclosed. The tellurium-containing compound is utilized in combination with a chemotherapeutic agent and/or radiation, such that the female treated by the chemotherapeutic agent and/or radiation and by the tellurium-containing compound is instructed to refrain from conceptive sex for a pre-determined time period, following the chemotherapy and/or radiotherapy, during which conception is undesired. The tellurium-containing compound is utilized in combination with a chemotherapeutic agent and/or radiation, such that the female treated by the chemotherapeutic agent and/or radiation and by the tellurium-containing compound is instructed to refrain from sex and/or from reproduction for a pre-determined time period, and is then allowed to practice reproduction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160076556-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102397510-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019175459-A1 |
| priorityDate |
2009-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |